CONSHOHOCKEN, PA — Cencora, Inc. (NYSE: COR), a leading global healthcare company, recently announced a significant transition in its executive leadership. Steven H. Collis, who has served as President and Chief Executive Officer for over a decade, will retire from his CEO role and assume the position of Executive Chair of the Board of Directors, effective October 1, 2024. Robert P. Mauch, PharmD, PhD, currently the Chief Operating Officer of Cencora, is set to succeed Collis as President and CEO, marking a new chapter in the company’s storied history.
Under Collis’s stewardship, Cencora has witnessed remarkable growth, with annual revenues soaring to exceed $250 billion, a testament to the company’s robust expansion in both domestic and international markets. Collis’s tenure as CEO since 2011 has been marked by strategic diversification and the successful establishment of Cencora as a global brand, positioning the company for continued success in the healthcare sector.
“Steve’s 30-year career at Cencora has been characterized by purpose-driven leadership and phenomenal growth,” said Mark Durcan, Lead Independent Director of Cencora. He lauded Collis for his visionary leadership and his role in transforming Cencora into a global healthcare leader, with a presence in over 50 countries and a workforce of 46,000 team members.
Collis reflected on his tenure with pride, emphasizing the strategic investments and partnerships that have cemented Cencora’s industry leadership position. He expressed confidence in Mauch’s ability to lead the company forward, noting their nearly two decades of close collaboration.
Robert P. Mauch, poised to become the third CEO in Cencora’s 23-year history, brings a wealth of experience and a deep understanding of the company’s operations. His leadership has been integral to Cencora’s evolution into a unified, global provider of pharmaceutical-centric healthcare solutions. The Board of Directors expressed confidence in Mauch’s ability to continue driving Cencora’s momentum and creating value for stakeholders.
“I am honored to succeed Steve as President and CEO of Cencora,” said Mauch, expressing gratitude for Collis’s mentorship. He highlighted his motivation derived from the company’s adaptability and innovation in meeting partners’ needs and pledged to advance Cencora’s pharmaceutical-centric strategy.
This leadership transition is part of a carefully planned succession strategy, ensuring continuity and stability at Cencora. As Collis steps into his new role as Executive Chair, and Mauch prepares to lead as CEO, Cencora is well-positioned to continue its trajectory of growth and innovation in the healthcare industry.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.